The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Heineman Thomas Charles since 2026.
This trader's CIK number is 2103579.
At the time of last reporting, Heineman Thomas Charles was the Chief Medical Officer of Oncolytics Biotech Inc. (stock ticker symbol ONCY).
Also see all insider trading activities at Oncolytics Biotech Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2026 | ONCY | 12,132 | $10,033 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-02-12 | ONCY | Buy | 12,132 | .83 | 10,033 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Heineman Thomas Charles (Chief Medical Officer of Oncolytics Biotech Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.